Holen Sie sich die Stockscreener-App
25.31
1.33%
-0.34
Handel nachbörslich:
25.30
-0.010
-0.04%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$25.65
Offen:
$25.71
24-Stunden-Volumen:
3.91M
Relative Volume:
0.73
Marktkapitalisierung:
$13.09B
Einnahmen:
$11.32B
Nettoeinkommen (Verlust:
$-981.00M
KGV:
-12.96
EPS:
-1.9532
Netto-Cashflow:
$714.00M
1W Leistung:
+0.12%
1M Leistung:
+7.75%
6M Leistung:
+37.48%
1J Leistung:
+10.09%
1-Tages-Spanne:
$25.20
$25.71
1-Wochen-Bereich:
$23.62
$25.71
52-Wochen-Spanne:
$15.73
$30.00
Baxter International Inc Stock (BAX) Company Profile
Firmenname
Baxter International Inc
Sektor
Telefon
(224) 948-2000
Adresse
ONE BAXTER PARKWAY, DEERFIELD, IL
Compare BAX vs ISRG, BDX, RMD, ALC, MDLN
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
BAX
Baxter International Inc
|
25.31 | 13.09B | 11.32B | -981.00M | 714.00M | -1.9532 |
ISRG
Intuitive Surgical Inc
|
452.29 | 159.78B | 11.03B | 3.16B | 3.22B | 8.7251 |
BDX
Becton Dickinson Co
|
198.84 | 54.16B | 21.37B | 1.41B | 3.07B | 3.9437 |
RMD
Resmed Inc
|
252.75 | 35.55B | 5.54B | 1.52B | 1.74B | 10.37 |
ALC
Alcon Inc
|
70.22 | 33.95B | 10.63B | 819.00M | 1.59B | 1.6577 |
MDLN
Medline Inc
|
34.08 | 29.90B | 29.14B | 1.07B | 1.05B | 1.1956 |
Baxter International Inc Stock (BAX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-10-20 | Eingeleitet | Wolfe Research | Peer Perform |
| 2026-10-07 | Eingeleitet | Barclays | Underweight |
| 2026-07-31 | Hochstufung | Citigroup | Sell → Neutral |
| 2026-05-28 | Herabstufung | Citigroup | Neutral → Sell |
| 2025-10-31 | Herabstufung | Argus | Buy → Hold |
| 2025-08-04 | Herabstufung | Stifel | Buy → Hold |
| 2025-08-01 | Herabstufung | Goldman | Buy → Neutral |
| 2025-02-26 | Fortgesetzt | Goldman | Buy |
| 2025-02-24 | Hochstufung | Argus | Hold → Buy |
| 2025-02-20 | Fortgesetzt | Barclays | Overweight |
| 2024-07-15 | Herabstufung | Morgan Stanley | Equal-Weight → Underweight |
| 2024-05-30 | Eingeleitet | Goldman | Neutral |
| 2024-05-10 | Herabstufung | TD Cowen | Buy → Hold |
| 2023-05-30 | Fortgesetzt | Morgan Stanley | Equal-Weight |
| 2023-03-29 | Eingeleitet | UBS | Neutral |
| 2023-01-06 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2023-01-05 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2023-01-03 | Herabstufung | BofA Securities | Buy → Neutral |
| 2022-12-19 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2022-12-15 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2022-12-12 | Herabstufung | Citigroup | Buy → Neutral |
| 2022-10-18 | Eingeleitet | Barclays | Overweight |
| 2022-10-12 | Eingeleitet | Jefferies | Hold |
| 2022-06-24 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2022-04-04 | Herabstufung | Goldman | Neutral → Sell |
| 2022-03-02 | Fortgesetzt | BofA Securities | Buy |
| 2022-02-18 | Bestätigt | KeyBanc Capital Markets | Overweight |
| 2022-02-18 | Bestätigt | Morgan Stanley | Overweight |
| 2022-02-18 | Bestätigt | Raymond James | Outperform |
| 2022-02-18 | Bestätigt | Stifel | Buy |
| 2022-02-18 | Bestätigt | UBS | Neutral |
| 2022-02-18 | Bestätigt | Wells Fargo | Overweight |
| 2022-02-11 | Eingeleitet | Goldman | Neutral |
| 2022-01-07 | Fortgesetzt | Citigroup | Buy |
| 2022-01-07 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2021-09-13 | Hochstufung | Cowen | Market Perform → Outperform |
| 2021-09-03 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2021-05-25 | Eingeleitet | Barclays | Equal Weight |
| 2021-01-29 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2021-01-06 | Herabstufung | UBS | Buy → Neutral |
| 2020-12-15 | Herabstufung | Goldman | Buy → Neutral |
| 2020-10-01 | Hochstufung | Citigroup | Neutral → Buy |
| 2020-09-04 | Herabstufung | Argus | Buy → Hold |
| 2020-06-24 | Eingeleitet | Oppenheimer | Outperform |
| 2020-03-19 | Hochstufung | Stifel | Hold → Buy |
| 2020-03-18 | Hochstufung | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2020-03-05 | Eingeleitet | Citigroup | Neutral |
| 2020-02-13 | Eingeleitet | Goldman | Buy |
| 2020-01-02 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2019-12-17 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2019-06-26 | Eingeleitet | KeyBanc Capital Markets | Sector Weight |
| 2019-04-08 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2019-01-02 | Hochstufung | Citigroup | Neutral → Buy |
| 2019-01-02 | Hochstufung | Morgan Stanley | Underweight → Overweight |
| 2018-11-02 | Hochstufung | Argus | Hold → Buy |
| 2018-10-16 | Eingeleitet | Barclays | Underweight |
| 2018-05-17 | Fortgesetzt | Piper Jaffray | Overweight |
| 2018-02-06 | Bestätigt | Citigroup | Neutral |
| 2018-01-03 | Eingeleitet | Evercore ISI | Outperform |
| 2018-01-03 | Hochstufung | Raymond James | Mkt Perform → Outperform |
Alle ansehen
Baxter International Inc Aktie (BAX) Neueste Nachrichten
Baxter International Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
Why Baxter (BAX) Stock Is Down Today - Yahoo Finance
FDA Issues Warning Letter to Baxter International (BAX) Over Man - GuruFocus
Baxter International Inc. stock outperforms competitors despite losses on the day - MarketWatch
Issuance/retirement of debt (net) of Baxter International Inc. – HAN:BTL - TradingView
Baxter International Inc. stock underperforms Friday when compared to competitors - MarketWatch
Baxter International Inc. (BAX) Stock Forecasts - Yahoo Finance
Baxter International Inc (BAX) Shares Surge 3.9% -- What GF Scor - GuruFocus
Baxter International: The Vantive Transition Complicates Margin Recovery - Seeking Alpha
Baxter’s Quarterly Earnings Preview: What You Need to Know - Yahoo Finance
Baxter International Inc. (BAX) Options Chain - Yahoo! Finance Canada
Baxter International Inc. (BAX) Options ChainYahoo Finance - Yahoo! Finance Canada
Baxter International Inc. stock outperforms competitors on strong trading day - MarketWatch
Baxter International Inc. (BAX) Options Chain - Yahoo! Finance Canada
Barclays Initiates Baxter International Inc(BAX.US) With Sell Rating, Announces Target Price $20 - Moomoo
Baxter International Inc. stock outperforms competitors despite losses on the day - MarketWatch
Baxter International Inc. stock outperforms competitors despite losses on the day - MarketWatch
Baxter to Host Third-Quarter 2026 Financial Results Conference Call for Investors - FinancialContent
Baxter to Host Third-Quarter 2026 Financial Results Conference Call for Investors - Yahoo Finance
BAX Initiates Coverage On Baxter International -- Rating Set to Underweight - GuruFocus
Evercore ISI Adjusts Price Target on Baxter International to $32 From $24 - marketscreener.com
Baxter International Initiated at Underweight by Barclays - Moomoo
Barclays Initiates Coverage on Baxter International With Underweight Rating, $20 Price Target - www.marketscreener.com
Baxter International Inc. (BAX) Stock Forecasts - Yahoo Finance
Citigroup cuts target for Baxter International stock from USD 28.00 to USD 27.00 - AD HOC NEWS
Baxter International Price Target Cut to $27.00/Share From $28.00 by Citigroup - Moomoo
Citigroup Trims Price Target on Baxter International to $27 From $28, Keeps Neutral Rating - Moomoo
Are Investors Undervaluing Baxter International (BAX) Right Now? - Zacks Investment Research
Is Baxter International (BAX) Stock Outpacing Its Medical Peers This Year? - Zacks Investment Research
Is Baxter International (BAX) Stock Outpacing Its Medical Peers This Year? - Yahoo Finance
Are Investors Undervaluing Baxter International (BAX) Right Now? - Yahoo Finance
Citigroup cuts target for Baxter International stock to USD 27.00 - AD HOC NEWS
Baxter International Inc (BAX) Stock Up 3.1% and Still Undervalued -- GF Score: 70/100 - GuruFocus
Baxter International Inc. stock outperforms competitors on strong trading day - MarketWatch
Zacks cuts Baxter estimate and Baxter International stock gains 1.49 percent - AD HOC NEWS
Baxter Releases Inaugural Connected Hospital Report - Bioscience Association Manitoba
Citigroup Trims Price Target on Baxter International to $27 From $28, Keeps Neutral Rating - marketscreener.com
BAX5072770 Bond Profile: Coupon and Redemption - TradingView
BAX.GQ Bond Profile: Coupon and Redemption - TradingView
Baxter International stock after-hours at EUR 20.82: minus 0.95 percent versus prior close - AD HOC NEWS
Can Execution Lift Baxter International (NYSE:BAX) From Here? - Kalkine Media
Baxter International Inc. stock underperforms Thursday when compared to competitors - MarketWatch
BAX5072771 Bond Profile: Coupon and Redemption - tradingview.com
Baxter International Inc. stock outperforms competitors on strong trading day - MarketWatch
What Investors Might Be Missing On Baxter International (BAX) - Yahoo Finance
Baxter Releases Inaugural Connected Hospital Report - Business Wire
Why Investors Need to Take Advantage of These 2 Medical Stocks Now - Zacks Investment Research
Baxter International stock trades above analyst target - ad-hoc-news.de
Baxter International stock heads into the open after a 1.9 percent S&P 500 drop - AD HOC NEWS
Here's Why You Should Retain Baxter Stock in Your Portfolio for Now - TradingView
Finanzdaten der Baxter International Inc-Aktie (BAX)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.96%
0.70%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):